(Q48606576)

13 February 2018

title

Blood and CSF biomarkers for AD revisited: what's new, what's good, and is this where we should be looking? (English)

1 reference

13 February 2018

1 reference

1

1 reference

13 February 2018

publication date

1 July 2002

1 reference

13 February 2018

published in

Neurobiology of Aging

1 reference

13 February 2018

volume

23

1 reference

13 February 2018

issue

4

1 reference

13 February 2018

page(s)

517-9; discussion 521-2

1 reference

13 February 2018

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900349-9

7 January 2021

Biological markers of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900349-9

7 January 2021

Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900349-9

7 January 2021

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900349-9

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900349-9

7 January 2021

Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900349-9

7 January 2021

Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900349-9

7 January 2021

Review of the next generation of Alzheimer's disease therapeutics: challenges for drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900349-9

7 January 2021

Imaging Alzheimer's amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900349-9

7 January 2021

10.1016/S0197-4580(01)00349-9

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018